Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

BACKGROUND: Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab response in rheumatoid arthritis (RA) to aid timely switching in non-responder patie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Res Ther
Asıl Yazarlar: OIiver, James, Nair, Nisha, Orozco, Gisela, Smith, Samantha, Hyrich, Kimme L., Morgan, Ann, Isaacs, John, Wilson, Anthony G., Barton, Anne, Plant, Darren
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948368/
https://ncbi.nlm.nih.gov/pubmed/33691749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02451-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller